
PEPG Investors Have Opportunity To Lead Pepgen Inc. Securities Fraud Lawsuit With The Schall Law Firm
LOS ANGELES, July 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PepGen Inc. ("PepGen" or "the Company") (NASDAQ: PEPG ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between March 7, 2024 through March 3, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 8, 2025.
If you are a shareholder who suffered a loss, click here to participate .
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at , or by email at [email protected] .
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. PepGen's drug candidate PGN-EDO51 was less safe and effective than it claimed to investors. The Company's CONNECT2 study was deficient for purposes of FDA approval and was dangerous to participants. The Company was likely to halt its CONNECT2 study. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about PepGen, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
Office: 310-301-3335
[email protected]
SOURCE The Schall Law Firm
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Bitmex Study Reveals 90% Drop In Extreme Bitcoin Perpetual Futures Funding Rates Since 2016, Signalling Market Maturation
- Primexbt Partners With Theo Wassenaar Primary School To Support Education In South Africa
- Alchemy Markets Unveils Major Rebrand, Ushering In A New Era Of Financial Empowerment
- GBM Launches Auction Festival With The Sandbox, Aavegotchi, Unstoppable Domains, And More
- Everstake Brings Ethereum Experts Together To Explore Post-Pectra And Institutional Adoption
- Gelato And Morpho Partner To Offer Embedded Crypto-Backed Loans For Wallets, Brokers, And Fintech Apps
Comments
No comment